EQS-Adhoc: CompuGroup Medical SE & Co. KGaA confirms discussions for potential significant investment of CVC
|
EQS-Ad-hoc: CompuGroup Medical SE & Co. KGaA / Key word(s): Tender Offer CompuGroup Medical SE & Co. KGaA (Company) confirms that the Company and the shareholder group around the founding family Gotthardt are in advanced discussions with the private equity firm CVC Capital Partners plc (CVC) regarding a potential conclusion of an investment agreement for the submission of a voluntary public tender offer to the shareholders of the Company. The discussions also include a later delisting of shares of the Company from the regulated market. Starting point is a potential offer price of EUR 22.00 per share that CVC has indicated to the Company in the event of a public tender offer, which is subject, in particular, to final board decisions and the signing of transaction documents.
In the event of the potential transaction being implemented, the shareholder group around the Gotthardt family intends to remain invested in the Company to the same extent as before, with around 50,1% and, subject to the outcome of the ongoing discussions, to establish a strategic partnership with CVC. The Company will inform the public and the capital market about further relevant developments in accordance with the legal requirements. End of Inside Information
08-Dec-2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | CompuGroup Medical SE & Co. KGaA |
| Maria Trost 21 | |
| 56070 Koblenz | |
| Germany | |
| Phone: | +49 (0)160 3630362 |
| Fax: | +49 (0)261 8000 3200 |
| E-mail: | investor@cgm.com |
| Internet: | www.cgm.com |
| ISIN: | DE000A288904 |
| WKN: | A28890 |
| Indices: | SDAX, TecDAX |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 2046393 |
| End of Announcement | EQS News Service |
|
|
2046393 08-Dec-2024 CET/CEST
Boersengefluester.de (BGFL) provides an overview of the key figures on sales, earnings, cash flow and dividends to help you better assess the fundamental development of the respective companies. All information is entered manually in our database - the source is the respective annual reports. All estimates for future figures are provided by BGFL.
| The most important financial data at a glance | ||||||||
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024e | ||
| Sales1 | 717,02 | 745,81 | 837,26 | 1.025,32 | 1.129,74 | 1.187,66 | 1.165,00 | |
| EBITDA1,2 | 187,84 | 178,13 | 197,48 | 213,39 | 216,35 | 229,76 | 235,00 | |
| EBITDA-Margin3 | 26,20 | 23,88 | 23,59 | 20,81 | 19,15 | 19,35 | 20,17 | |
| EBIT1,4 | 143,23 | 115,27 | 121,77 | 102,68 | 104,03 | 98,00 | 0,00 | |
| EBIT-Margin5 | 19,98 | 15,46 | 14,54 | 10,01 | 9,21 | 8,25 | 0,00 | |
| Net Profit (Loss)1 | 96,34 | 66,15 | 73,42 | 69,03 | 74,12 | 46,87 | 0,00 | |
| Net-Margin6 | 13,44 | 8,87 | 8,77 | 6,73 | 6,56 | 3,95 | 0,00 | |
| Cashflow1,7 | 136,35 | 110,50 | 149,93 | 165,27 | 145,03 | 179,53 | 0,00 | |
| Earnings per share8 | 1,92 | 1,33 | 1,40 | 1,30 | 1,40 | 0,88 | 0,89 | |
| Dividend per share8 | 0,50 | 0,50 | 0,50 | 0,50 | 0,50 | 1,00 | 0,50 | |
1 in Mio. Euro; 2 EBITDA = Earnings before interest, taxes, depreciation and amortisation; 3 EBITDA in relation to sales; 4 EBIT = Earnings before interest and taxes; 5 EBIT in relation to sales; 6 Net profit (-loss) in relation to sales; 7 Cashflow from operations; 8 in Euro; Source: boersengefluester.de
Auditor: KPMG
All relevant valuation ratios, dates and other investor information on your share at a glance. Good to know: All data comes from boersengefluester.de and is updated daily. This means you are always up to date. You can get brief explanations of the key figures by moving the cursor or mouse over the relevant field.
| INVESTOR-INFORMATION | ||||||
| ©boersengefluester.de | ||||||
| CompuGroup Medical | ||||||
| WKN | ISIN | Legal Type | Marketcap | IPO | Recommendation | Plus Code |
| A28890 | DE000A288904 | SE & Co. KGaA | 1.168,19 Mio € | 04.05.2007 | Halten | 9F299HQG+3H |
| PE 2025e | PE 10Y-Ø | BGFL-Ratio | Shiller-PE | PB | PCF | KUV |
| 18,58 | 35,62 | 0,52 | 18,66 | 2,01 | 6,51 | 0,98 |
|
Dividend '2022 in € |
Dividend '2023 in € |
Dividend '2024e in € |
Div.-Yield '2024e in % |
| 0,50 | 1,00 | 0,50 | 2,30% |
| Annual General Meeting | Q1-figures | Q2-figures | Q3-figures | Annual press conference |
| 14.05.2025 | 30.04.2025 | 31.07.2025 | 07.11.2024 | 06.03.2025 |
| Distance 60-days-line | Distance 200-days-line | Performance YtD | Performance 52 weeks | IPO |
| +39,48% | +7,68% | -42,64% | -41,37% | +20,78% |
Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.
Contact
